Medication-related osteonecrosis of the jaw associated with pazopanib monotherapy (2022)
Source: International Journal of Odontostomatology. Unidade: FOB
Subjects: OSTEONECROSE, MANDÍBULA, ONCOLOGIA
ABNT
CAMINHA, Raquel D'Aquino Garcia et al. Medication-related osteonecrosis of the jaw associated with pazopanib monotherapy. International Journal of Odontostomatology, v. 16, n. 1, p. 23-26, 2022Tradução . . Disponível em: https://doi.org/10.4067/S0718-381X2022000100023. Acesso em: 06 nov. 2024.APA
Caminha, R. D. 'A. G., Simpione, G., Lara, V. S., & Santos, P. S. da S. (2022). Medication-related osteonecrosis of the jaw associated with pazopanib monotherapy. International Journal of Odontostomatology, 16( 1), 23-26. doi:10.4067/S0718-381X2022000100023NLM
Caminha RD'AG, Simpione G, Lara VS, Santos PS da S. Medication-related osteonecrosis of the jaw associated with pazopanib monotherapy [Internet]. International Journal of Odontostomatology. 2022 ; 16( 1): 23-26.[citado 2024 nov. 06 ] Available from: https://doi.org/10.4067/S0718-381X2022000100023Vancouver
Caminha RD'AG, Simpione G, Lara VS, Santos PS da S. Medication-related osteonecrosis of the jaw associated with pazopanib monotherapy [Internet]. International Journal of Odontostomatology. 2022 ; 16( 1): 23-26.[citado 2024 nov. 06 ] Available from: https://doi.org/10.4067/S0718-381X2022000100023